Patents of polymorphic forms in the pharmaceutical field in Brazil, and its impact on public health

Authors

  • Jaqueline Mendes Soares Instituto Nacional da Propriedade Industrial, Área de patentes de fármacos, Praça Mauá, Centro, Rio de Janeiro, RJ, Brasil
  • Marilena Cordeiro Dias Villela Correa Universidade do Estado do Rio de Janeiro, Instituto de Medicina Social, Maracanã, Rio de Janeiro, RJ, Brasil
  • Liane Elizabeth Caldeira Lage Instituto Nacional da Propriedade Industrial, Praça Mauá, Centro, Rio de Janeiro, RJ, Brasil

DOI:

https://doi.org/10.3395/reciis.v4i2.679

Keywords:

medications, polymorphs, crystal form

Abstract

The aim of this article is to show how the National Institute of Industrial Property (INPI) is examining the patent applications related to the polymorphic forms in the pharmaceutical field. In order to do so, there was a survey regarding the number of patent applications in this field. Such applications had already been examined by the INPI from January 2008 to March 2009. Results show that most of the patent applications neither meet some of the patentability requirements, nor some of the descriptive sufficiency condition requirements, in accordance with the legal provisions of Law 9279/96 (LPI) and the exam draft guidelines developed by the Institute.

Published

2010-06-30

How to Cite

Soares, J. M., Correa, M. C. D. V., & Lage, L. E. C. (2010). Patents of polymorphic forms in the pharmaceutical field in Brazil, and its impact on public health. Revista Eletrônica De Comunicação, Informação & Inovação Em Saúde, 4(2). https://doi.org/10.3395/reciis.v4i2.679

Issue

Section

Original articles